GlassScriptPhysician profile
Richard Paul
NPI 1174524920
$2,008.58
in general payments reported to CMS, 2019-2025
9 companies · $2.38 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,034 · 2020: $158 · 2021: $219 · 2022: $445 · 2023: $127 · 2024: $24.73 · 2025: $2.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148 · Education: $6.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.55 |
| Education | $6.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $853.26 | 2019-2023 | Farxiga |
| Pfizer INC. | $358.86 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $301.95 | 2019-2023 | Jynarque |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.32 | 2019-2022 | |
| Amgen INC. | $151.37 | 2019-2022 | |
| Vifor Pharma, INC. | $47.92 | 2019 | |
| Fresenius USA Marketing, INC. | $39.89 | 2019-2024 | Velphoro |
| Travere Therapeutics, INC. | $19.78 | 2019-2025 | Filspari |
| Horizon Therapeutics Plc | $14.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.